Decipher Labs Share Price

BSE
DECIPHER •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Decipher Labs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
39.81% Fall from 52W High
-8.3
TTM PE Ratio
Below industry Median
18.8
Price to Book Ratio
Low in industry
0.7
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is less than 1
0.2

Decipher Labs Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Decipher Labs Ltd Quarterly Revenue

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
5.87 Cr
7.44 Cr
10.59 Cr
8.29 Cr
7.49 Cr

Decipher Labs Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
36.3 Cr
52.94 Cr
73 Cr
56.21 Cr
24.26 Cr

Decipher Labs Ltd Quarterly Net Profit/Loss

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
-1.33 Cr
0.95 Cr
1.2 Cr
0.01 Cr
-1.94 Cr

Decipher Labs Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
-1.68 Cr
-2.68 Cr
11.38 Cr
1.4 Cr
1.1 Cr

Decipher Labs Ltd shareholding Pattern

Promoter
16.4%
Public
83.6%
Promoter
16.4%
Public
83.6%
Promoter
16.4%
Public
83.6%
Promoter
16.4%
Public
83.6%
Promoter
16.4%
Public
83.6%
Promoter
16.4%
Public
83.6%

Decipher Labs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
16.00
10Day EMA
16.00
12Day EMA
16.00
20Day EMA
15.90
26Day EMA
15.90
50Day EMA
16.00
100Day EMA
16.30
200Day EMA
16.90
5Day SMA
16.00
10Day SMA
16.10
20Day SMA
15.80
30Day SMA
15.70
50Day SMA
15.80
100Day SMA
16.50
150Day SMA
16.80
200Day SMA
16.70
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
3676 Rs
4246 Rs
Week Rs
7455 Rs
9294 Rs
Month Rs
8806 Rs
10861 Rs
Resistance & Support
15.99
Pivot
Resistance
First Resistance
16.26
Second Resistance
16.66
Third Resistance
16.93
Support
First Support
15.59
Second support
15.32
Third Support
14.92
Relative Strength Index
49.87
Money Flow Index
70.65
MACD
0.09
MACD Signal
0.07
Average True Range
0.84
Average Directional Index
13.98
Rate of Change (21)
4.07
Rate of Change (125)
-15.28

Decipher Labs Ltd Company background

Founded in: 1986
Decipher Labs Ltd. (formerly known as Combat Drugs Ltd) was incorporated as a Private Limited Company in September, 1986 and was converted into a Public Limited Company in Jun.92. The company was promoted by Suchit Mohan Lal and Ajay Karan. The Company is a professionally managed, well established, diversified Public Limited Company, engaged in the Manufacture Marketing of Pharmaceuticals and allied products and services and providing Services and key Solutions in Information Technology Industry. Since inception, the Company has been manufacturing marketing its branded formulations and custom manufacturing for various companies besides supplies of various Bulk drugs, chemicals and Finished Formulations. During the years of operations, it has garnered a reputation as a quality provider in the Pharmaceutical industry and the Products marketed by the Company have been well accepted by the Trade and Medical Fraternity across India.The Company also diversified interest in the field on Information Technology and has developed a name for itself as a key solution provider in the field of associated technologies. It expanded by reviving the Information Technology wing and started dealing and reviving its associations into the Information Technology Industry. To increase presence in the Information Technology segment, the Company acquired Decipher Software Solutions LLC in USA to add good volumes to the overall turnover and Profits of the Company. The Company came out with a public issue of 23.23 lac equity shares at par aggregating Rs 2.32 cr in Nov.94. The proceeds of the issue were utilised to partfinance a Rs 3.25cr project to expand the existing manufacturing facilities for pharmaceutical formulations and to diversify into the manufacture of sterile powder injectables.CDL started commercial production in Jul.87 on a loanlicence basis. The company acquired a fullfledged manufacturing unit located at Balanagar, Hyderabad, on lease from Fairchild Laboratories and commenced commercial production in Aug.88. In Jul.92 the manufacturing activities were shifted to the present leased premises at Kushaiguda, Hyderabad. In this unit various pharmaceutical formulations such as tablets, capsules and liquids are being manufactured. The product range of CDL comprises vital antibacterial drugs, antibiotic drugs, antiinflammatory drugs, haematenic drugs and protein tonic. CDL has developed inhouse technology for the manufacture of dispersible and sustained release formulations. The company is exploring the possibilities of exporting its products to Nigeria and West Indies. During the year 199596, the expansion programme undertaken by the company was successfully completed and the unit at Yellampet has become operational.During 199697, the company has expanded its operations to new areas. It has expanded its product range by introduction of Liquid Orals. The product HB 2 has been well accepted in the market. The company has also filled its application for obtaining the (c)GMP and WHO GMP Certificate.
Read More

Decipher Labs Ltd FAQs

You can easily buy Decipher Labs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -